Search research articles
Contact Us
Filters
Showing results (71-80 of 484) with videos related to
Page
of 49
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 18, 2017
Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis
Yannick Allanore, Oliver Distler, Marco Matucci-Cerinic, et al.
Plos One
|
July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
Joanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 20, 2016
Reply
Vincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Medical Hypotheses
|
June 3, 2018
Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?
Michael Hughes, Andrea Murray, Christopher P Denton, et al.
The Journal of Rheumatology
|
September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
Ivan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Autoimmunity Reviews
|
February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping review
Sabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease
Lutz Wollin, Jörg Hw Distler, Christopher P Denton, et al.
Seminars in Arthritis and Rheumatism
|
January 20, 2024
Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial
Elana J Bernstein, Christopher P Denton, Suiyuan Huang, et al.
Rheumatology (Oxford, England)
|
June 22, 2012
Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy
Pia Moinzadeh, Korsa Khan, Voon H Ong, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review
Aaron Tan, Christopher P Denton, Dimitri P Mikhailidis, et al.
Page
of 49
Search research articles
Search
Showing results (71-80 of 484) with videos related to
Sort By:
Page
of 49
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 18, 2017
Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis
Yannick Allanore, Oliver Distler, Marco Matucci-Cerinic, et al.
Plos One
|
July 29, 2015
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin
Joanna Nikitorowicz-Buniak, Christopher P Denton, David Abraham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 20, 2016
Reply
Vincent Sobanski, Jonathan Giovannelli, Christopher P Denton, et al.
Medical Hypotheses
|
June 3, 2018
Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?
Michael Hughes, Andrea Murray, Christopher P Denton, et al.
The Journal of Rheumatology
|
September 17, 2010
Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort
Ivan Foeldvari, Svetlana I Nihtyanova, Angela Wierk, et al.
Autoimmunity Reviews
|
February 19, 2017
Towards developing criteria for scleroderma renal crisis: A scoping review
Sabrina Hoa, Edward P Stern, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Rationale for the evaluation of nintedanib as a treatment for systemic sclerosis-associated interstitial lung disease
Lutz Wollin, Jörg Hw Distler, Christopher P Denton, et al.
Seminars in Arthritis and Rheumatism
|
January 20, 2024
Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial
Elana J Bernstein, Christopher P Denton, Suiyuan Huang, et al.
Rheumatology (Oxford, England)
|
June 22, 2012
Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy
Pia Moinzadeh, Korsa Khan, Voon H Ong, et al.
Clinical and Experimental Rheumatology
|
May 19, 2011
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review
Aaron Tan, Christopher P Denton, Dimitri P Mikhailidis, et al.
Page
of 49